Avita Therapeutics(AVH.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

AVH.AU Avita Therapeutics

Not Yet Opened 05-16 16:12:00 AEST

2.48

-0.13

-4.98%

High2.54	Low2.48	Vol858.93K
Open2.51	D1 Closing2.61	Amplitude2.30%
Mkt Cap319.63M	Tradable Cap7.72M	Total Shares128.88M
T/O2.15M	T/O Rate27.60%	Tradable Shares3.11M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"AVH.AU","market":"AU","secType":"STK","nameCN":"Avita Therapeutics","latestPrice":2.48,"timestamp":1715839920000,"preClose":2.61,"halted":0,"volume":858928,"delay":0,"nameEN":"Avita Therapeutics","floatShares":3112087,"shares":128881755,"eps":-21.10547556474015,"marketStatus":"Not Yet Opened","change":-0.13,"latestTime":"05-16 16:12:00 AEST","open":2.51,"high":2.54,"low":2.48,"amount":2152587,"amplitude":0.022989,"askPrice":2.5,"askSize":10350,"bidPrice":2.48,"bidSize":21112,"shortable":3,"etf":0,"ttmEps":-21.10547556474015,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1715904000000},"marketStatusCode":0,"adr":0,"adrRate":8,"exchange":"ASX","adjPreClose":2.61,"openAndCloseTimeList":[[1715817600000,1715839200000]],"volumeRatio":1.598577,"lotSize":1,"tradeCurrency":"AUD"},"requestUrl":"/m/hq/s/AVH.AU/wiki","defaultTab":"wiki","newsList":[{"id":"2435638655","title":"AVITA Medical Inc (AVHHL) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2435638655","media":"GuruFocus.com","top":-1,"share":"https://ttm.financial/m/news/2435638655?lang=en_us&edition=fundamental","pubTime":"2024-05-14 15:04","pubTimestamp":1715670270,"startTime":"0","endTime":"0","summary":"Commercial Revenue: $11.1 million for Q1 2024, a 5.8% increase year-over-year but below expectations.Gross Profit Margin: Increased to 86.4% from 84.2% in Q1 2023.Operating Expenses: Rose to $26.8 million from $19.4 million in Q1 2023.Net Loss: $18.7 million, or $0.73 per share, compared to $9.2 million, or $0.37 per share in Q1 2023.Cash and Equivalents: $68.1 million as of March 31, 2024, down from $89.1 million as of December 31, 2023.Q2 2024 Revenue Guidance: Expected to be between $14.3 million and $15.3 million.Full Year 2024 Revenue Guidance: Reaffirmed at $78.5 million to $84.5 million, indicating a growth of approximately 57% at the lower end.GuruFocus has detected 1 Warning Sign with AVHHL.AVITA Medical Inc  has successfully passed major MDR conformity assessment audits, advancing towards obtaining a CE Mark for RECELL GO in the European Union.AVITA Medical Inc  reported disappointing first-quarter commercial revenue of $11.1 million, falling short of expectations and marking","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/avita-medical-inc-avhhl-q1-070430381.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2435532764","title":"2 ASX healthcare shares rocking higher on big news","url":"https://stock-news.laohu8.com/highlight/detail?id=2435532764","media":"MotleyFool","top":-1,"share":"https://ttm.financial/m/news/2435532764?lang=en_us&edition=fundamental","pubTime":"2024-05-14 10:58","pubTimestamp":1715655527,"startTime":"0","endTime":"0","summary":"ASX healthcare shares are one of only two market sectors trading in the green at the time of writing. The S&P/ASX 200 Health Care Index (ASX: XHJ) is up 0.55% and is the best sector of the day so far.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/05/14/2-asx-healthcare-shares-rocking-higher-on-big-news/","is_publish_highlight":false,"gpt_icon":0},{"id":"2435304801","title":"3 ASX shares at 52-week lows or worse","url":"https://stock-news.laohu8.com/highlight/detail?id=2435304801","media":"MotleyFool","top":-1,"share":"https://ttm.financial/m/news/2435304801?lang=en_us&edition=fundamental","pubTime":"2024-05-14 03:32","pubTimestamp":1715628720,"startTime":"0","endTime":"0","summary":"The market may be trading close to its record high, but the same cannot be said for the ASX shares in this article.Much to the dismay of their shareholders, these shares have just hit 52-week lows or worse. Here's what you need to know:. The AVITA Medical share price dropped to a 52-week low of $2.54 on Monday. This means that the regenerative medicine company's shares have now lost around a third of their value over the last 12 months.Almost all of this decline was generated last month when the company released its first-quarter sales update. That update revealed that AVITA Medicalexpects to report commercial revenue in the range of US$11 million to US$11.3 million for the quarter. This compares to its previous guidance of US$14.8 million to US$15.6 million.Management advised that its guidance downgrade is attributable to a slower-than-expected conversion rate of new accounts for its expanded label of full-thickness skin defects.Interestingly, its first quarter results are being relea","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/05/14/3-asx-shares-at-52-week-lows-or-worse/","is_publish_highlight":false,"gpt_icon":1},{"id":"2435659963","title":"Morgans names the best small cap ASX shares to buy in May","url":"https://stock-news.laohu8.com/highlight/detail?id=2435659963","media":"MotleyFool","top":-1,"share":"https://ttm.financial/m/news/2435659963?lang=en_us&edition=fundamental","pubTime":"2024-05-13 06:03","pubTimestamp":1715551380,"startTime":"0","endTime":"0","summary":"If you have a higher-than-average tolerance for risk, then you might want to consider adding somesmall caps to your investment portfolio. But which small cap ASX shares should you buy?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/05/13/morgans-names-the-best-small-cap-asx-shares-to-buy-in-may/","is_publish_highlight":false,"gpt_icon":0},{"id":"2434969138","title":"AVITA Medical Inc    expected to post a loss of 47 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2434969138","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2434969138?lang=en_us&edition=fundamental","pubTime":"2024-05-11 04:03","pubTimestamp":1715371393,"startTime":"0","endTime":"0","summary":"* AVITA Medical Inc     is expected to show a rise in quarterly revenue when it reports  results on May 13 for the period ending March 31 2024   * The Valencia California California-based  company is ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432695404","title":"This fundie invested in Neuren at a $70m valuation. It's now $2.4 billion.","url":"https://stock-news.laohu8.com/highlight/detail?id=2432695404","media":"LiveWire","top":-1,"share":"https://ttm.financial/m/news/2432695404?lang=en_us&edition=fundamental","pubTime":"2024-05-02 09:00","pubTimestamp":1714611605,"startTime":"0","endTime":"0","summary":"The newly minted KP Rx Healthcare Opportunities Fund, managed by Hashan De Silva, comes from a strong pedigree.De Silva previously worked for Karst Peak, a spinoff from Tiger Management, run by legendary hedge fund manager Julian Robertson.Karst Peak founder Adam Leitzes is providing seed capital for KP Rx, following the playbook of Robertson, who seeded and mentored numerous ex-employees to run their own investment houses - affectionately known as \"Tiger cubs\".In addition to the seed capital from Karst Peak, KP Rx’s investors include some of Australia’s most successful healthcare entrepreneurs including Dr Chris Behrenbruch , Patrick Davies , Lou Panaccio  to name a few.The fund is not focused on GP clinics, hospitals, or healthcare services. Rather, it focuses on later-stage businesses, with De Silva describing KP Rx as a \"series A, B, or C investor, where we are coming in once a lot of the initial preclinical stuff has been done.\". Previous successful investments include now ASX-lis","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/this-fundie-invested-in-neuren-at-a-70m-valuation-it-s-now-2-4-billion","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/this-fundie-invested-in-neuren-at-a-70m-valuation-it-s-now-2-4-billion","is_publish_highlight":false,"gpt_icon":0},{"id":"2427019860","title":"Why Avita Medical, NextDC, Predictive Discovery, and Star shares are tumbling today","url":"https://stock-news.laohu8.com/highlight/detail?id=2427019860","media":"MotleyFool","top":-1,"share":"https://ttm.financial/m/news/2427019860?lang=en_us&edition=fundamental","pubTime":"2024-04-15 11:13","pubTimestamp":1713150799,"startTime":"0","endTime":"0","summary":"In afternoon trade, theS&P/ASX 200 Index(ASX: XJO) is on course to start the week with a disappointing decline. At the time of writing, the benchmark index is down 0.55% to 7,745.1 points. Four ASX sh","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/04/15/why-avita-medical-nextdc-predictive-discovery-and-star-shares-are-tumbling-today/","is_publish_highlight":false,"gpt_icon":0},{"id":"2426260532","title":"Why Avita Medical, Cettire, Domino's Pizza, and Star shares are falling today","url":"https://stock-news.laohu8.com/highlight/detail?id=2426260532","media":"MotleyFool","top":-1,"share":"https://ttm.financial/m/news/2426260532?lang=en_us&edition=fundamental","pubTime":"2024-04-12 12:02","pubTimestamp":1712894554,"startTime":"0","endTime":"0","summary":"TheS&P/ASX 200 Index is having a subdued finish to the week. In afternoon trade, the benchmark index is down 0.25% to 7,794.4 points.Four ASX shares that are falling more than most today are listed below. Here's why they are dropping:. The Star Entertainment share price is down 8% to 50.2 cents. This follows the release of a trading update from the struggling casino and resorts operator. Unfortunately for shareholders, the company reported net revenue of $419.2 million for the three months. This is down 4.6% from $439.5 million in the prior corresponding period. Management blamed the weakness on its Premium Gaming Rooms  revenue, which was down sharply across all of its properties during the quarter. Also falling during the quarter were its earnings. Star's EBITDA was down 11.5% to $37.9 million for the period.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/04/12/why-avita-medical-cettire-dominos-pizza-and-star-shares-are-falling-today/","is_publish_highlight":false,"gpt_icon":0},{"id":"2426147682","title":"AVITA Medical drops revenue forecast for Q1","url":"https://stock-news.laohu8.com/highlight/detail?id=2426147682","media":"The Market Herald","top":-1,"share":"https://ttm.financial/m/news/2426147682?lang=en_us&edition=fundamental","pubTime":"2024-04-12 07:07","pubTimestamp":1712876820,"startTime":"0","endTime":"0","summary":"Wound care and skin restoration developer AVITA Medical  provided an update on its anticipated revenue for Q1 2024 – and has downgraded its commercial revenue guidance for the quarter.For CY Q1 ending on March 31, 2024, AVITA Medical now anticipates commercial revenue to be between US$11.0 million and US$11.3 million. This forecast is lower than the previously estimated range of US$14.8 million to US$15.6 million. The adjustment is attributed to a slower-than-expected conversion rate of new accounts for the expanded use of its products in treating full-thickness skin defects.In saying that – despite the updated revision, AVITA Medical remains optimistic about its growth prospects. Since introducing its expanded label for full-thickness skin defects in June 2023, the company has acquired 73 new accounts, including 22 in the first quarter of 2024. Additionally, there are 71 submissions under evaluation by the value analysis committee  as of March 31, 2024.“While our account conversion ra","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://themarketonline.com.au/avita-medical-drops-revenue-forecast-for-q1-2024-04-12/","is_publish_highlight":false,"gpt_icon":0},{"id":"2426287935","title":"ASX 200 dodges US CPI bullet on surging base and precious metals, energy, and battery stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2426287935","media":"LiveWire","top":-1,"share":"https://ttm.financial/m/news/2426287935?lang=en_us&edition=fundamental","pubTime":"2024-04-11 15:53","pubTimestamp":1712822019,"startTime":"0","endTime":"0","summary":"The S&P/ASX 200  finished 34.9 points lower at 7,813.6, 0.79% from its session low and just 0.45% from its high. In the broader-based S&P/ASX 300 , advancers lagged decliners by a dismal 90 to to 190.The Energy   sector was the best performing sector today, likely in response to a modest rise in the price of crude oil and natural gas overnight. This was an important rally for the sector today as it snapped a 3-day losing streak and also confirmed a bounce off key short term trend ribbon support.An important bounce off the key short term trend ribbon. Also doing well today was the Gold   sub-index, but really, Resources   in general had a very good run. This was due to a combination of higher base and precious metals prices overnight, as well as some favourable inflation data out of China. Note the impact of the data on the session chart above, I discuss it in further detail in Economy.What could make them so desperate to get in regardless of price?Well, as a technical analyst I really ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/asx-200-dodges-us-cpi-bullet-on-surging-base-and-precious-metals-energy-and-battery-stocks","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/asx-200-dodges-us-cpi-bullet-on-surging-base-and-precious-metals-energy-and-battery-stocks","is_publish_highlight":false,"gpt_icon":0},{"id":"2426828565","title":"Market Close: Real-estate ends Thursday bruised, after overnight US surprise","url":"https://stock-news.laohu8.com/highlight/detail?id=2426828565","media":"The Market Herald","top":-1,"share":"https://ttm.financial/m/news/2426828565?lang=en_us&edition=fundamental","pubTime":"2024-04-11 14:25","pubTimestamp":1712816700,"startTime":"0","endTime":"0","summary":"The ASX200 closed down 0.45 of a per cent.The energy sector lead gains, up 1.16 per cent. Real-estate fell the most, down one and three quarters of a per cent. Financials and Health care both lost around point nine of a per cent.In this bulletin Vulcan Energy Resources, Core lithium, Sunshine Metals, Peninsula Energy, AVITA Medical and Charger Metals.Earlyresults revealed grades of 90 to 95% lithium, achieved throughVulcan’s adsorption-type direct lithium extraction  unit.Vulcan says this marksthe first company to produce lithium chemicals from a local source in Europe.Core lithium  gained around three and a half per cent, after it revealed a 58% surge in its Mineral Resource Estimate.Anextensive drilling campaign undertaken in 2023 stands as the largest program ever executed by the company, according to the company.The firmis prepared to commence construction at the site immediately, according to Peninsula Energy.AVITA Medical  fell nearly 10% after itdowngraded its revenue guidance.A","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://themarketonline.com.au/market-close-real-estate-ends-thursday-bruised-after-overnight-us-surprise-2024-04-11/","is_publish_highlight":false,"gpt_icon":0},{"id":"2426414401","title":"Why Avita Medical, Netwealth, Peninsula Energy, and Zip shares are sinking today","url":"https://stock-news.laohu8.com/highlight/detail?id=2426414401","media":"MotleyFool","top":-1,"share":"https://ttm.financial/m/news/2426414401?lang=en_us&edition=fundamental","pubTime":"2024-04-11 12:17","pubTimestamp":1712809061,"startTime":"0","endTime":"0","summary":"The S&P/ASX 200 Index (ASX: XJO) is having a tough session on Thursday following a hotter than expected US inflation reading. In afternoon trade, the benchmark index is down 0.5% to 7,811.4 points. Fo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/04/11/why-avita-medical-netwealth-peninsula-energy-and-zip-shares-are-sinking-today/","is_publish_highlight":false,"gpt_icon":0},{"id":"2426405185","title":"Market Update: Energy keeps light bright in a sea of red","url":"https://stock-news.laohu8.com/highlight/detail?id=2426405185","media":"The Market Herald","top":-1,"share":"https://ttm.financial/m/news/2426405185?lang=en_us&edition=fundamental","pubTime":"2024-04-11 11:13","pubTimestamp":1712805180,"startTime":"0","endTime":"0","summary":"The ASX is down .7 of a per cent with every sector – except energy – in the red.Real estate is taking a dive – the sector has lost nearly 2 per cent mid-session.In other news this morning – the ABS has released the monthly business turnover indicator. Business turnover for the Mining industry had the largest monthly fall in February of 9.6 per cent. The ABS says the fall in Mining turnover was largely due to declining commodity prices, particularly iron ore.Wound care and skin restoration developer AVITA Medical  is down nearly 11 per cent after providing an update on its anticipated revenue for Q1 2024 – and downgrading its commercial revenue guidance for the quarter.Vulcan Energy  is up nearly 14 per cent on news it’sbecome the first company to produce lithium chemicals from their Lithium Extraction Optimisation Plant  in Germany – hoped to be used on the continent,And Haranga Resources has announced the results from 19 recent RC drillholes on-site at its Senegalese uranium acreage.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://themarketonline.com.au/market-update-energy-keeps-light-bright-in-a-sea-of-red-2024-04-11/","is_publish_highlight":false,"gpt_icon":0},{"id":"2426474953","title":"Why did this ASX All Ords stock just crash 16%?","url":"https://stock-news.laohu8.com/highlight/detail?id=2426474953","media":"MotleyFool","top":-1,"share":"https://ttm.financial/m/news/2426474953?lang=en_us&edition=fundamental","pubTime":"2024-04-11 09:39","pubTimestamp":1712799547,"startTime":"0","endTime":"0","summary":"The All Ordinaries Index(ASX: XAO) is down 0.8% in morning trade, and it's certainly not being helped by this tumbling ASX All Ords stock. The company in question is ASX healthcare stock Avita Medical","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/04/11/why-did-this-asx-all-ords-stock-just-crash-16/","is_publish_highlight":false,"gpt_icon":0},{"id":"2426475798","title":"BUZZ-AVITA Medical's ASX shares drop to 3-month low on revenue forecast downgrade","url":"https://stock-news.laohu8.com/highlight/detail?id=2426475798","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2426475798?lang=en_us&edition=fundamental","pubTime":"2024-04-11 09:05","pubTimestamp":1712797503,"startTime":"0","endTime":"0","summary":"** ASX-listed shares of AVITA Medical Inc    fall as much as 16.2% to A$3.770, their lowest since Jan 8   ** Stock set for worst day since Oct 3, if losses hold   ** Co expects March-qtr commercial revenue between $11 mln and $11.3 mln, lower than previous forecast of $14.8 mln to $15.6 mln   ** Says the downward revision due to slower-than-expected conversion rate of new accounts for expanded label of full-thickness skin defects   ** AVH top loser on ASX All Ordinaries index      ** As of last close, stock up 4.9% this year ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2425646196","title":"AVITA Medical (NASDAQ:RCEL) investors are sitting on a loss of 42% if they invested five years ago","url":"https://stock-news.laohu8.com/highlight/detail?id=2425646196","media":"Simply Wall St.","top":-1,"share":"https://ttm.financial/m/news/2425646196?lang=en_us&edition=fundamental","pubTime":"2024-04-07 22:19","pubTimestamp":1712499542,"startTime":"0","endTime":"0","summary":"While not a mind-blowing move, it is good to see that the AVITA Medical, Inc.  share price has gained 14% in the last three months. But that doesn't change the fact that the returns over the last five years have been less than pleasing. After all, the share price is down 42% in that time, significantly under-performing the market.Now let's have a look at the company's fundamentals, and see if the long term shareholder return has matched the performance of the underlying business.AVITA Medical isn't currently profitable, so most analysts would look to revenue growth to get an idea of how fast the underlying business is growing. Shareholders of unprofitable companies usually desire strong revenue growth. As you can imagine, fast revenue growth, when maintained, often leads to fast profit growth.Over five years, AVITA Medical grew its revenue at 37% per year. That's well above most other pre-profit companies. The share price drop of 7% per year over five years would be considered let down","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/fZxxC7WFAddugsI0.C6IZw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/fZxxC7WFAddugsI0.C6IZw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/avita-medical-nasdaq-rcel-investors-141902930.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422573507","title":"3 struggling ASX shares to buy at a discount","url":"https://stock-news.laohu8.com/highlight/detail?id=2422573507","media":"MotleyFool","top":-1,"share":"https://ttm.financial/m/news/2422573507?lang=en_us&edition=fundamental","pubTime":"2024-03-26 03:30","pubTimestamp":1711395000,"startTime":"0","endTime":"0","summary":"Against the grain of a bullish market, there are some quality companies that have dropped out of favour recently. They might be fighting through a one-off difficulty or adverse external conditions tha","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/03/26/3-struggling-asx-shares-to-buy-at-a-discount/","is_publish_highlight":false,"gpt_icon":0},{"id":"2420433146","title":"This AVITA Medical Insider Increased Their Holding By 250% Last Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2420433146","media":"Simply Wall St.","top":-1,"share":"https://ttm.financial/m/news/2420433146?lang=en_us&edition=fundamental","pubTime":"2024-03-17 21:50","pubTimestamp":1710683426,"startTime":"0","endTime":"0","summary":"Viewing insider transactions for AVITA Medical, Inc.'s  over the last year, we see that insiders were net buyers. This means that a larger number of shares were purchased by insiders in relation to shares sold.While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we would consider it foolish to ignore insider transactions altogether.The Last 12 Months Of Insider Transactions At AVITA Medical. We note that there's been a little more insider selling than buying, recently. But the difference isn't enough to have us worried. But insiders have shown more of an appetite for the stock, over the last year. Overall we don't see anything to make us think AVITA Medical insiders are doubting the company, and they do own sha","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/fZxxC7WFAddugsI0.C6IZw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/fZxxC7WFAddugsI0.C6IZw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/avita-medical-insider-increased-holding-135026053.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2414079815","title":"ASX 200 edges higher as Kogan blows past expectations, TPG, NIB and Endeavour disappoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2414079815","media":"LiveWire","top":-1,"share":"https://ttm.financial/m/news/2414079815?lang=en_us&edition=fundamental","pubTime":"2024-02-26 16:22","pubTimestamp":1708935726,"startTime":"0","endTime":"0","summary":"The S&P/ASX200  finished 9.2 points higher at7,652.8 , 0.21% from its session low and 0.40% from its high. In the broader-based S&P/ASX 300 , advancers beat decliners by 153 to 114.The Gold   sub-sector was the best performing sector today, partly due to the gold price edging higher since our last update, but more likely in response to a strong performance from Gold Road Resources   which was the beneficiary of several positive broker reports following its full year results on Friday.The sector has been doing it tough of late, so today's broad based gains are no doubt welcome among ASX gold bugs!Also doing well today was the Consumer Discretionary   and Information Technology   sectors, both following up their strong performances from last week. Much of the recent performance is due to a few sector heavyweights within both sectors respectively reporting strong / better than expected results.Boss shareholders will be hoping its a case of buying the pullback, and it couldn't come too soo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/asx-200-edges-higher-as-kogan-blows-past-expectations-tpg-nib-and-endeavour-disappoint","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/asx-200-edges-higher-as-kogan-blows-past-expectations-tpg-nib-and-endeavour-disappoint","is_publish_highlight":false,"gpt_icon":0},{"id":"2414106031","title":"AVITA Medical, Inc. (NASDAQ:RCEL) Just Reported And Analysts Have Been Lifting Their Price Targets","url":"https://stock-news.laohu8.com/highlight/detail?id=2414106031","media":"Simply Wall St.","top":-1,"share":"https://ttm.financial/m/news/2414106031?lang=en_us&edition=fundamental","pubTime":"2024-02-25 21:24","pubTimestamp":1708867480,"startTime":"0","endTime":"0","summary":"AVITA Medical, Inc.  shareholders are probably feeling a little disappointed, since its shares fell 2.2% to US$17.10 in the week after its latest annual results. Revenues of US$50m came in 2.3% below estimates, but statutory losses were slightly better than expected, at US$1.46 per share. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. We thought readers would find it interesting to see the analysts latest  post-earnings forecasts for next year.The most obvious conclusion is that the analysts made no changes to their forecasts for a loss next year. Pleasantly, they also upgraded their revenue estimates, and their forecasts suggest the business is expected to grow faster than the wider industry. We note an upgrade to the price target, suggesting that the analysts believes the intrinsic","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/fZxxC7WFAddugsI0.C6IZw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/fZxxC7WFAddugsI0.C6IZw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/avita-medical-inc-nasdaq-rcel-132440410.html","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.carnegiece.com","stockEarnings":[{"period":"1week","weight":-0.0849},{"period":"1month","weight":-0.1678},{"period":"3month","weight":-0.5294},{"period":"6month","weight":-0.3474},{"period":"1year","weight":-0.3053},{"period":"ytd","weight":-0.4219}],"compareEarnings":[{"period":"1week","weight":0.014},{"period":"1month","weight":0.0594},{"period":"3month","weight":0.1011},{"period":"6month","weight":0.1412},{"period":"1year","weight":0.1534},{"period":"ytd","weight":0.1257}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Carnegie Clean Energy Limited develops and commercializes the CETO wave energy technology for converting ocean wave energy into zero-emission electricity worldwide. It also produces and sells clean renewable energy using solar-battery systems to the Department of Defense. The company was formerly known as Carnegie Wave Energy Limited and changed its name to Carnegie Clean Energy Limited in December 2016. Carnegie Clean Energy Limited is based in North Fremantle, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.272727,"avgChangeRate":-0.004702},{"month":2,"riseRate":0.136364,"avgChangeRate":-0.032428},{"month":3,"riseRate":0.5,"avgChangeRate":0.005125},{"month":4,"riseRate":0.363636,"avgChangeRate":-0.015565},{"month":5,"riseRate":0.380952,"avgChangeRate":0.869141},{"month":6,"riseRate":0.619048,"avgChangeRate":0.041156},{"month":7,"riseRate":0.428571,"avgChangeRate":0.046497},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.026094},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.067779},{"month":10,"riseRate":0.47619,"avgChangeRate":0.025174},{"month":11,"riseRate":0.363636,"avgChangeRate":0.005755},{"month":12,"riseRate":0.545455,"avgChangeRate":0.11845}],"exchange":"ASX","name":"Avita Therapeutics","nameEN":"Avita Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Avita Therapeutics(AVH.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Avita Therapeutics(AVH.AU) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Avita Therapeutics,AVH.AU,Avita Therapeutics股票,Avita Therapeutics股票老虎,Avita Therapeutics股票老虎国际,Avita Therapeutics行情,Avita Therapeutics股票行情,Avita Therapeutics股价,Avita Therapeutics股市,Avita Therapeutics股票价格,Avita Therapeutics股票交易,Avita Therapeutics股票购买,Avita Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Avita Therapeutics(AVH.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Avita Therapeutics(AVH.AU) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction